(difelikefalin)
Educational webinars, organised and funded by Vifor, and run by
experts in cardiology and nephrology to help support the
management of patients with HF and CKD
Nephrology Summit | November 25, 2022 | Manchester, UK
This promotional meeting was organised and funded by Vifor Pharma and was intended for Health Care Professionals only. The agenda and choice of speakers was developed by the steering committee. Prescribing information is provided from the location where this meeting recordings are hosted.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Vifor Pharma UK Ltd. (Tel 01276 853633). Email: medicalinfo_UK@viforpharma.com
Multiple long-term conditions in patients with CKD:
improving patient pathways and outcomes
TOPICS AND OBJECTIVES
Disseminate new data and insights from recently published trials with relevance for the management of patients with CKD
Share best practices on developing new services and approaches that focus on management of patients with CKD
Discuss inequalities in the care of patients with CKD
CHAIRS AND SPEAKERS
PROFESSOR DAVID WHEELER
Professor - University College London
Honorary Consultant Nephrologist -
Royal Free London NHS Foundation Trust
Steering Committee/Session Chair and Speaker
PROFESSOR HELEN HURST
Professor - University of Salford
Consultant Nurse - Salford Royal, Northern Care Alliance
Steering Committee/Session Chair
PROFESSOR PHILIP KALRA
Professor - University of Manchester
Director of Research and Innovation - Northern Care Alliance
Steering Committee/Session Chair
PROFESSOR SUNIL BHANDARI
Consultant Nephrologist - Hull University Teaching Hospitals NHS Trust
Honorary Clinical Professor - Hull York Medical School
Session speaker
DR KIERAN MCCAFFERTY
Honorary Senior Lecturer - Queen Mary University of London
Consultant Nephrologist - Barts Health NHS Trust
Session speaker
PROFESSOR INDRANIL DASGUPTA
Professor and Consultant in Nephrology and Hypertension - University Hospitals Birmingham NHS Foundation Trust
Steering Committee/Session speaker
PROFESSOR DEBASISH BANERJEE
Professor and Consultant Nephrologist
- St George’s, University of London & St George’s University Hospitals NHS Foundation Trust
Session speaker
PROFESSOR PAUL KALRA
Professor and Consultant Cardiologist - Portsmouth Hospitals University
NHS Trust
Session speaker
PROFESSOR JAMES BURTON
Professor and Consultant Nephrologist University of Leicester
Session speaker
PROFESSOR SMEETA SINHA
Consultant Nephrologist - Salford Royal Hospital, Northern Care Alliance
Session speaker
DR RANI KHATIB
Associate Professor - University of Leeds
Consultant Cardiology Pharmacist - Leeds Teaching Hospitals NHS Trust
Session speaker
MR FEZ AWAN
Patient Advocate
Chair of Renal Patient-Led Advisory
Panel member
DR JYOTI BAHARANI
Consultant Nephrologist and Associate Medical Director - Heartlands Hospital, University Hospitals Birmingham
Steering Committee/Session speaker
DR SOHAIL MUNSHI
GP and Chief Medical Officer - Chester and Trafford Local Care Organisations
Senior Clinical Adviser - Integration for NHS England and NHS improvement
Session speaker
SESSION 1: UPDATES ON RELEVANT TRIALS
Chair: Professor David Wheeler
Professor Sunil Bhandari: Multicentre randomised controlled trial of ACE inhibitor/ARB withdrawal in advanced kidney disease: The STOP-ACEi trial
Professor David Wheeler: SGLT2 inhibitors in non-diabetic CKD: What do the recent trials tell us?
Professor Indranil Dasgupta: The role of HIF stabilisers in the management of renal anaemia – insights from the ASCEND clinical trials programme
Dr Kieran McCafferty: Are we just scratching the surface of CKD-associated pruritus?
Professor Debasish Banerjee: Updates on management of patients with CKD using novel mineralocorticoid receptor antagonists
Professor Paul Kalra: Update on management of iron deficiency (ID) in heart failure
